Clinical Lab Molecular Diagnostics Test using QX200 ddPCR Instr.
Closed Pre-Solicitation Posted
- Solicitation number
- 75N98026Q00356
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Office of Logistics and Acquisition Operations intends to award a non-competitive contract for clinical laboratory molecular diagnostics testing using a QX200 ddPCR instrument, with capability statement and proposal submissions due May 28, 2026, at 9:00 AM Eastern time. This procurement is set aside for Total Small Business and carries a sole-source intent to Nexus Group LLC, though NIH reserves the right to conduct a competitive procurement based on responses received.
Work is performed at the Laboratory of Pathology, Center for Cancer Research in the Molecular Diagnostics Laboratory. The laboratory is the only CLIA and College of American Pathology approved clinical laboratory within the National Cancer Institute certified for molecular oncology testing on NIH patient materials and performs molecular testing to assist in cancer diagnosis, prognosis prediction, and identification of personalized therapy targets.
Estimated contract value does not exceed the simplified acquisition threshold of $350,000. The procurement falls under NAICS 334516 (Electronic Test and Measurement Instrument Manufacturing) with a $34 million size standard and PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies). The solicitation is conducted under FAR Part 13 Simplified Acquisition Procedures and FAR Subpart 13.106-1(b)(1).
Responses must include technical proposals, cost-price proposals, period of performance, UEI, Taxpayer Identification Number, and business size certification. Submit to Purchasing Agent Roshonna Davis at davisroshonna@mail.nih.gov.
Notice text
Attachment; Notice of Intent
Files
| File | Type | Posted |
|---|---|---|
| Notice of Intent to Sole Source Template - RD.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| Combined Synopsis Solicitation- Acquire Flow Cytom | Office of Logisitics and Acquisition Operations | No set-aside | |
| CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap) | Office of Logisitics and Acquisition Operations | No set-aside | |
| NIA:Non-Competitive Combined Synopsis/Solicitation | Office of Logisitics and Acquisition Operations | No set-aside | |
| DNA Sequencing Service | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity